AU2012253476B2 - Antimicrobial solid and methods of making and using same - Google Patents
Antimicrobial solid and methods of making and using same Download PDFInfo
- Publication number
- AU2012253476B2 AU2012253476B2 AU2012253476A AU2012253476A AU2012253476B2 AU 2012253476 B2 AU2012253476 B2 AU 2012253476B2 AU 2012253476 A AU2012253476 A AU 2012253476A AU 2012253476 A AU2012253476 A AU 2012253476A AU 2012253476 B2 AU2012253476 B2 AU 2012253476B2
- Authority
- AU
- Australia
- Prior art keywords
- bacteria
- antimicrobial
- solid
- solid material
- polyelectrolytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000845 anti-microbial effect Effects 0.000 title claims description 27
- 239000007787 solid Substances 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 14
- 241000894006 Bacteria Species 0.000 claims abstract description 51
- 239000004094 surface-active agent Substances 0.000 claims abstract description 33
- 229920000867 polyelectrolyte Polymers 0.000 claims description 24
- 239000004599 antimicrobial Substances 0.000 claims description 16
- 239000011148 porous material Substances 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 5
- 229920006037 cross link polymer Polymers 0.000 claims description 4
- 239000003093 cationic surfactant Substances 0.000 claims description 3
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 2
- 229940044192 2-hydroxyethyl methacrylate Drugs 0.000 claims description 2
- AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical compound OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 claims description 2
- NUYSYBDIPXEBHS-UHFFFAOYSA-N 3-(3-ethenylimidazol-1-ium-1-yl)propane-1-sulfonate Chemical compound [O-]S(=O)(=O)CCC[N+]=1C=CN(C=C)C=1 NUYSYBDIPXEBHS-UHFFFAOYSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000003945 anionic surfactant Substances 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 239000000017 hydrogel Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229940047670 sodium acrylate Drugs 0.000 claims description 2
- XIXDXIUWZQJVHJ-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;iodide Chemical compound [I-].CC(=C)C(=O)OCC[N+](C)(C)C XIXDXIUWZQJVHJ-UHFFFAOYSA-M 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 239000002563 ionic surfactant Substances 0.000 claims 1
- 239000011343 solid material Substances 0.000 abstract description 51
- 231100000518 lethal Toxicity 0.000 abstract description 3
- 230000001665 lethal effect Effects 0.000 abstract description 3
- 238000001228 spectrum Methods 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000007788 liquid Substances 0.000 description 19
- 239000000463 material Substances 0.000 description 19
- 239000000203 mixture Substances 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 12
- 239000011159 matrix material Substances 0.000 description 12
- 238000004132 cross linking Methods 0.000 description 9
- 239000003792 electrolyte Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- -1 HCl) Chemical class 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 229920002444 Exopolysaccharide Polymers 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000003139 biocide Substances 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
- WKALLSVICJPZTM-UHFFFAOYSA-N 3-[decyl(dimethyl)azaniumyl]propane-1-sulfonate Chemical compound CCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O WKALLSVICJPZTM-UHFFFAOYSA-N 0.000 description 1
- GUQQBLRVXOUDTN-XOHPMCGNSA-N 3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 GUQQBLRVXOUDTN-XOHPMCGNSA-N 0.000 description 1
- JYCQQPHGFMYQCF-UHFFFAOYSA-N 4-tert-Octylphenol monoethoxylate Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCO)C=C1 JYCQQPHGFMYQCF-UHFFFAOYSA-N 0.000 description 1
- ZVZFHCZCIBYFMZ-UHFFFAOYSA-N 6-methylheptoxybenzene Chemical compound CC(C)CCCCCOC1=CC=CC=C1 ZVZFHCZCIBYFMZ-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010043183 Teething Diseases 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- NLEBIOOXCVAHBD-QKMCSOCLSA-N dodecyl beta-D-maltoside Chemical compound O[C@@H]1[C@@H](O)[C@H](OCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NLEBIOOXCVAHBD-QKMCSOCLSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- YFVGRULMIQXYNE-UHFFFAOYSA-M lithium;dodecyl sulfate Chemical compound [Li+].CCCCCCCCCCCCOS([O-])(=O)=O YFVGRULMIQXYNE-UHFFFAOYSA-M 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- UMWKZHPREXJQGR-UHFFFAOYSA-N n-methyl-n-(2,3,4,5,6-pentahydroxyhexyl)decanamide Chemical compound CCCCCCCCCC(=O)N(C)CC(O)C(O)C(O)C(O)CO UMWKZHPREXJQGR-UHFFFAOYSA-N 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-O oxonium Chemical compound [OH3+] XLYOFNOQVPJJNP-UHFFFAOYSA-O 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000009428 plumbing Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- VMSNAUAEKXEYGP-YEUHZSMFSA-M sodium glycodeoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 VMSNAUAEKXEYGP-YEUHZSMFSA-M 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- WDFRNBJHDMUMBL-OICFXQLMSA-M sodium;(4r)-4-[(3r,5s,7r,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)CC1 WDFRNBJHDMUMBL-OICFXQLMSA-M 0.000 description 1
- HRQDCDQDOPSGBR-UHFFFAOYSA-M sodium;octane-1-sulfonate Chemical compound [Na+].CCCCCCCCS([O-])(=O)=O HRQDCDQDOPSGBR-UHFFFAOYSA-M 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 230000036346 tooth eruption Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Paints Or Removers (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015261645A AU2015261645B2 (en) | 2011-05-10 | 2015-11-26 | Antimicrobial solid and methods of making and using same |
| AU2017232218A AU2017232218B2 (en) | 2011-05-10 | 2017-09-24 | Antimicrobial solid and methods of making and using same |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161484558P | 2011-05-10 | 2011-05-10 | |
| US61/484,558 | 2011-05-10 | ||
| PCT/US2012/037320 WO2012154953A2 (en) | 2011-05-10 | 2012-05-10 | Antimicrobial solid and methods of making and using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015261645A Division AU2015261645B2 (en) | 2011-05-10 | 2015-11-26 | Antimicrobial solid and methods of making and using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012253476A1 AU2012253476A1 (en) | 2013-11-21 |
| AU2012253476B2 true AU2012253476B2 (en) | 2015-09-24 |
Family
ID=47140001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012253476A Ceased AU2012253476B2 (en) | 2011-05-10 | 2012-05-10 | Antimicrobial solid and methods of making and using same |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US10653133B2 (enExample) |
| EP (2) | EP2706845B1 (enExample) |
| JP (1) | JP6463629B2 (enExample) |
| AU (1) | AU2012253476B2 (enExample) |
| BR (1) | BR112013028673B1 (enExample) |
| CA (1) | CA2835211C (enExample) |
| WO (1) | WO2012154953A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100086576A1 (en) | 2008-10-06 | 2010-04-08 | Myntti Matthew F | Antimicrobial composition and methods of making and using same |
| WO2012154953A2 (en) | 2011-05-10 | 2012-11-15 | Microbial Defense Systems, Llc | Antimicrobial solid and methods of making and using same |
| AU2012318331B2 (en) * | 2011-10-08 | 2016-12-08 | Osartis Gmbh | Antimicrobial compositions and methods employing same |
| US10021876B2 (en) | 2013-05-02 | 2018-07-17 | Next Science IP Holdings Pty Ltd | High osmolarity antimicrobial composition containing one or more organic solvents |
| BR112018001002B1 (pt) | 2015-07-17 | 2022-06-21 | Next Science IP Holdings Pty Ltd | Composição antimicrobiana com eficácia contra endósporos |
| BR112018002548A2 (pt) | 2015-08-07 | 2018-09-18 | Next Science IP Holdings Pty Ltd | composição antimicrobiana com eficácia contra endoesporos |
| CN107332205A (zh) * | 2017-07-17 | 2017-11-07 | 日照南瑞电气科技有限公司 | 一种矿用隔爆型馈电开关保护装置 |
| CN113197200B (zh) * | 2021-04-30 | 2022-04-08 | 中国农业科学院植物保护研究所 | 农药分子噁霉灵作为胶凝剂的凝胶载药体系的制备方法及用途 |
| EP4580751A2 (en) | 2022-09-29 | 2025-07-09 | Adora Animal Health Corporation | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534259A (en) * | 1993-07-08 | 1996-07-09 | Liposome Technology, Inc. | Polymer compound and coated particle composition |
| US20030220039A1 (en) * | 1998-05-22 | 2003-11-27 | Fung-Jou Chen | Fibrous absorbent material and methods of making the same |
| WO2008016837A2 (en) * | 2006-07-31 | 2008-02-07 | Isp Investments Inc. | Aqueous compositions containing a hydrophobic material |
| WO2008024509A2 (en) * | 2006-08-24 | 2008-02-28 | Mallard Creek Polymers, Inc. | Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| WO2008076807A2 (en) * | 2006-12-13 | 2008-06-26 | Innovaform Technologies, Llc | Pesticidal aggregates |
Family Cites Families (127)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB983130A (en) | 1962-08-06 | 1965-02-10 | Mundipharma Ag | Improvements in preparations for the removal of wax from the ear |
| US4002775A (en) | 1973-07-09 | 1977-01-11 | Kabara Jon J | Fatty acids and derivatives of antimicrobial agents |
| US4067997A (en) | 1975-05-21 | 1978-01-10 | Med-Chem Laboratories | Synergistic microbecidal composition and method |
| CA1052273A (en) | 1975-12-18 | 1979-04-10 | Edwin B. Michaels | Antimicrobial compositions |
| US4323551A (en) | 1981-02-19 | 1982-04-06 | The Procter & Gamble Company | Mouthwash compositions |
| US5166331A (en) | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| US5208257A (en) | 1986-04-21 | 1993-05-04 | Kabara Jon J | Topical antimicrobial pharmaceutical compositions and methods |
| US5017229A (en) | 1990-06-25 | 1991-05-21 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
| US5290552A (en) | 1988-05-02 | 1994-03-01 | Matrix Pharmaceutical, Inc./Project Hear | Surgical adhesive material |
| IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| US5575815A (en) | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
| CA2019719A1 (en) | 1990-06-25 | 1991-12-25 | William J. Thompson | Mouthwash |
| EP0466397A3 (en) | 1990-07-10 | 1992-05-06 | Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo | Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters |
| US5662913A (en) | 1991-04-10 | 1997-09-02 | Capelli; Christopher C. | Antimicrobial compositions useful for medical applications |
| DE69229548T2 (de) | 1991-04-10 | 2000-02-17 | Christopher C. Capelli | Antimikrobielle zusammensetzungen für medizinische anwendungen |
| US5326492A (en) * | 1991-11-18 | 1994-07-05 | Medical Polymers, Inc. | Disinfectant mixture containing water soluble lubricating and cleaning agents and method |
| US5229103A (en) | 1992-04-30 | 1993-07-20 | Hydrodent Laboratories, Inc. | Antiplaque mouthwash concentrate |
| IT1260154B (it) | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
| GB9218834D0 (en) | 1992-09-05 | 1992-10-21 | Procter & Gamble | Nasal spray products |
| CN1091315A (zh) | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | 血纤维蛋白封闭剂组合物及其使用方法 |
| US5362442A (en) | 1993-07-22 | 1994-11-08 | 2920913 Canada Inc. | Method for sterilizing products with gamma radiation |
| US5480658A (en) | 1993-07-23 | 1996-01-02 | Melman; Steven A. | Ear and skin cleanser |
| US5543383A (en) * | 1994-12-30 | 1996-08-06 | Hampshire Chemical Corp. | Herbicidal compositions comprising solutions of glyphosate and polyurea and/or polyurethane |
| US6086921A (en) | 1995-04-25 | 2000-07-11 | Wintrop-University Hospital | Metal/thiol biocides |
| CA2230530C (en) | 1995-08-29 | 2004-04-27 | Fidia Advanced Biopolymers, Srl | Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
| FI955389A0 (fi) | 1995-11-09 | 1995-11-09 | Antti Sakari Aaltonen | Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener |
| US6423694B1 (en) | 1996-02-21 | 2002-07-23 | Inspire Pharmaceuticals, Inc. | Method of treating otitis media with uridine triphosphates and related compounds |
| US6541460B2 (en) | 1996-08-07 | 2003-04-01 | George D. Petito | Method for use of hyaluronic acid in wound management |
| US5910420A (en) | 1996-08-16 | 1999-06-08 | Orion-Yhtyma Oy Orion Diagnostica | Method and test kit for pretreatment of object surfaces |
| US6063061A (en) | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US6203822B1 (en) | 1996-09-03 | 2001-03-20 | University Of Iowa Research Foundation | Gallium-containing compounds for the treatment of infections caused by intracellular pathogens and pathogens causing chronic pulmonary infection |
| IL129237A0 (en) | 1996-10-01 | 2000-02-17 | Smithkline Beecham Corp | Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| CO4910145A1 (es) | 1996-10-01 | 2000-04-24 | Smithkline Beecham Corp | Uso |
| IT1287967B1 (it) | 1996-10-17 | 1998-09-10 | Fidia Spa In Amministrazione S | Preparazioni farmaceutiche per uso anestetico locale |
| US5709546A (en) | 1996-11-27 | 1998-01-20 | Waggoner; Mark B. | Water sanitizing system and process |
| FR2756739B1 (fr) | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
| PT975790E (pt) | 1997-01-24 | 2005-01-31 | Schweiz Serum & Impfinst | Novo metodo para isolar polissacaridos |
| US6869938B1 (en) | 1997-06-17 | 2005-03-22 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
| US5925334A (en) | 1997-08-27 | 1999-07-20 | Rubin; Bruce K. | Use of surface active agents to promote mucus clearance |
| US6638621B2 (en) | 2000-08-16 | 2003-10-28 | Lyotropic Therapeutics, Inc. | Coated particles, methods of making and using |
| DE69831421T2 (de) | 1997-12-02 | 2006-06-22 | Archimedes Development Ltd. | Zusammensetzungen zur nasalen verabreichung |
| US5895781A (en) | 1997-12-22 | 1999-04-20 | S. C. Johnson & Son, Inc. | Cleaning compositions for ceramic and porcelain surfaces and related methods |
| DE69811407T2 (de) | 1997-12-24 | 2003-11-20 | Britannia Pharmaceuticals Ltd., Redhill | Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs |
| IL123143A (en) | 1998-02-02 | 2001-08-26 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
| US7691829B2 (en) | 1998-03-24 | 2010-04-06 | Petito George D | Composition and method for healing tissues |
| US6824793B1 (en) | 1998-06-01 | 2004-11-30 | Chiron Corporation | Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
| US20030079758A1 (en) | 1998-06-03 | 2003-05-01 | Siegel Phyllis B. | Process and composition for removing biofilm |
| US6706290B1 (en) | 1998-07-06 | 2004-03-16 | Olvai E. Kajander | Methods for eradication of nanobacteria |
| US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| GB9822170D0 (en) | 1998-10-13 | 1998-12-02 | Danbioyst Uk Ltd | Novel formulations of fexofenadine |
| JP2002529545A (ja) | 1998-11-06 | 2002-09-10 | ユニベルシテ ドゥ モントリオール | バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液 |
| US8197461B1 (en) | 1998-12-04 | 2012-06-12 | Durect Corporation | Controlled release system for delivering therapeutic agents into the inner ear |
| US6149822A (en) | 1999-03-01 | 2000-11-21 | Polymer Ventures, Inc. | Bio-film control |
| US6673053B2 (en) * | 1999-05-07 | 2004-01-06 | Scimed Life Systems, Inc. | Hydrophilic lubricity coating for medical devices comprising an antiblock agent |
| US6375963B1 (en) | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
| US6521431B1 (en) * | 1999-06-22 | 2003-02-18 | Access Pharmaceuticals, Inc. | Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments |
| US6576224B1 (en) | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| US6533749B1 (en) | 1999-09-24 | 2003-03-18 | Medtronic Xomed, Inc. | Angled rotary tissue cutting instrument with flexible inner member |
| KR100722502B1 (ko) | 1999-09-24 | 2007-05-28 | 알콘, 인코퍼레이티드 | 사이프로플록사신 및 덱사메타손 함유 국소용 현탁제 |
| US6676930B2 (en) | 1999-11-28 | 2004-01-13 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| GB0002229D0 (en) | 2000-02-01 | 2000-03-22 | Reckitt & Colman Inc | Improvements in or relating to organic compositions |
| CA2397496C (en) | 2000-02-28 | 2007-07-24 | The Procter & Gamble Company | Acidic antimicrobial compositions for treating food and food contact surfaces and methods of use thereof |
| JP4074067B2 (ja) * | 2000-04-25 | 2008-04-09 | 和光純薬工業株式会社 | 抗原生生物製剤 |
| CA2410796C (en) | 2000-06-05 | 2007-05-01 | S.C. Johnson & Son, Inc. | Biocidal cleaning method |
| EP1286589A2 (fr) | 2000-06-08 | 2003-03-05 | Rhodia Chimie | Composition et procede pour le traitement biocide des surfaces |
| US6953772B2 (en) | 2000-07-18 | 2005-10-11 | Lopes John A | Concentrated sanitizing compositions for cleaning food and food contact surfaces |
| AUPQ893200A0 (en) | 2000-07-21 | 2000-08-17 | Whiteley, Reginald K. | Medical residue treatment |
| US20030133883A1 (en) | 2001-06-14 | 2003-07-17 | Finnegan Mary Beth | Oral care compositions containing grapefruit seed extract |
| US6623513B2 (en) | 2001-01-19 | 2003-09-23 | Advanced Photodynamic Technologies, Inc. | Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin |
| US6610314B2 (en) | 2001-03-12 | 2003-08-26 | Kimberly-Clark Worldwide, Inc. | Antimicrobial formulations |
| AU2002303832A1 (en) | 2001-05-21 | 2002-12-03 | Beth Israel Deaconess Medical Center, Inc. | P.aeruginosa mucoid exopolysaccharide specific binding peptides |
| WO2003026671A1 (en) | 2001-09-21 | 2003-04-03 | Alcon, Inc. | Method of treating middle ear infections |
| US20030095890A1 (en) | 2001-09-24 | 2003-05-22 | Shirley Miekka | Methods for sterilizing biological materials containing non-aqueous solvents |
| US20030064000A1 (en) | 2001-09-24 | 2003-04-03 | Wilson Burgess | Methods of sterilizing biological mixtures using stabilizer mixtures |
| US6701940B2 (en) | 2001-10-11 | 2004-03-09 | S. C. Johnson & Son, Inc. | Hard surface cleaners containing ethylene oxide/propylene oxide block copolymer surfactants |
| EP1441831A4 (en) * | 2001-10-19 | 2005-10-26 | Innovative Constr & Build Mat | ANTIPATHOGENIC AIR FILTER MEDIA AND AIR INTAKE DEVICE WITH PROTECTIVITY AGAINST INFECTIOUS FLUID MICROORGANISMS |
| WO2003035278A1 (en) * | 2001-10-25 | 2003-05-01 | Massachusetts Institute Of Technology | Method of depositing polyelectrolyte multilayers and articles coated thereby |
| US7381715B2 (en) * | 2001-12-21 | 2008-06-03 | E.I. Du Pont De Nemours And Company | Antimicrobial solid surface materials containing chitosan-metal complexes |
| AU2003205227A1 (en) | 2002-01-18 | 2003-09-02 | Emory University | Phthalocyanine and porphyrazine pharmaceutical compositions |
| US20050042240A1 (en) | 2002-01-28 | 2005-02-24 | Utterberg David S. | High viscosity antibacterials |
| AU2003225073A1 (en) | 2002-04-18 | 2003-11-03 | The University Of Iowa Research Foundation | Methods of inhibiting and treating bacterial biofilms by metal chelators |
| US6919348B2 (en) | 2002-05-02 | 2005-07-19 | Edward T. Wei | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
| EP1374856A1 (en) | 2002-06-18 | 2004-01-02 | Impetus AG | Oily thixotropic nasal spray |
| WO2004024187A2 (en) | 2002-09-13 | 2004-03-25 | Zicam, Llc. | Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| US20050064508A1 (en) | 2003-09-22 | 2005-03-24 | Semzyme | Peptide mediated synthesis of metallic and magnetic materials |
| AU2003279067A1 (en) | 2002-09-23 | 2004-04-08 | Genta Inc. | Tri(alkylcarboxylato) gallium (iii) products and pharmaceutical compositions containing them |
| US20040101506A1 (en) | 2002-11-25 | 2004-05-27 | Fust Charles A. | Composition for the prevention and treatment of inflammation of the ear |
| US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| GB2397067B (en) | 2002-12-23 | 2005-05-11 | Destiny Pharma Ltd | Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation |
| US7544192B2 (en) | 2003-03-14 | 2009-06-09 | Sinexus, Inc. | Sinus delivery of sustained release therapeutics |
| US20040214753A1 (en) | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| US7090882B2 (en) | 2003-06-12 | 2006-08-15 | Cargill, Incorporated | Antimicrobial salt solutions for food safety applications |
| US20050003007A1 (en) | 2003-07-02 | 2005-01-06 | Michele Boix | Method of sterilization of polymeric microparticles |
| US7341983B2 (en) | 2003-08-04 | 2008-03-11 | Ecolab Inc. | Antimicrobial compositions including carboxylic acids and alkoxylated amines |
| MXPA06001776A (es) | 2003-08-15 | 2007-09-07 | Qlt Usa Inc | Sistema de suministro de farmaco transmucosal biocorrosivo, adhesivo. |
| US20050080396A1 (en) | 2003-10-03 | 2005-04-14 | Michael Rontal | Method and apparatus for the ultrasonic cleaning of biofilm coated surfaces |
| EP1691614B1 (en) | 2003-12-04 | 2013-02-13 | University Of Iowa Research Foundation | Gallium inhibits biofilm formation |
| CN1917889A (zh) | 2003-12-17 | 2007-02-21 | 泰坦医药品公司 | 镓在治疗炎性关节炎中的用途 |
| JP2007517042A (ja) | 2003-12-30 | 2007-06-28 | デュレクト コーポレーション | 活性物質、好ましくはｇｎｒｈの制御放出のための、好ましくはｐｅｇおよびｐｌｇの混合物を含有するポリマーインプラント |
| US20100016267A1 (en) | 2004-03-15 | 2010-01-21 | Felix Theeuwes | Pharmaceutical compositions for administraton to a sinus |
| US7238363B2 (en) | 2004-04-02 | 2007-07-03 | Baylor College Of Medicine | Modification of medical prostheses |
| US7803150B2 (en) | 2004-04-21 | 2010-09-28 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
| US7410480B2 (en) | 2004-04-21 | 2008-08-12 | Acclarent, Inc. | Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
| US20050282722A1 (en) | 2004-06-16 | 2005-12-22 | Mcreynolds Kent B | Two part cleaning composition |
| US7494963B2 (en) | 2004-08-11 | 2009-02-24 | Delaval Holding Ab | Non-chlorinated concentrated all-in-one acid detergent and method for using the same |
| US20060045850A1 (en) | 2004-08-30 | 2006-03-02 | Qpharma, Llc | Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids |
| US9028852B2 (en) | 2004-09-07 | 2015-05-12 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
| CN103181400B (zh) | 2004-09-10 | 2016-08-10 | 诺维信北美公司 | 防止、去除、减少或破坏生物膜的方法 |
| CN101137359B (zh) | 2005-03-10 | 2011-01-12 | 3M创新有限公司 | 治疗耳感染的方法 |
| WO2006099386A2 (en) | 2005-03-11 | 2006-09-21 | Massachusetts Institute Of Technology | Synthesis and use of colloidal iii-v nanoparticles |
| US8486472B2 (en) | 2006-01-18 | 2013-07-16 | Cargill, Incorporated | Antimicrobial salt solutions for food safety applications |
| US20070166344A1 (en) * | 2006-01-18 | 2007-07-19 | Xin Qu | Non-leaching surface-active film compositions for microbial adhesion prevention |
| US7976873B2 (en) | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
| US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
| US20070264296A1 (en) | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
| US7959943B2 (en) | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
| EP2173161A1 (en) | 2007-06-19 | 2010-04-14 | Cellular Bioengineering, Inc. | Method for treating microorganisms and/or infectious agents |
| JP5151429B2 (ja) * | 2007-12-05 | 2013-02-27 | 住友化学株式会社 | 水性懸濁状農薬組成物 |
| WO2009103717A1 (en) * | 2008-02-18 | 2009-08-27 | Dsm Ip Assets B.V. | Coating composition comprising an antimicrobial cross-linker |
| RU2513142C2 (ru) | 2008-06-12 | 2014-04-20 | Медтроник Ксомед Инк. | Способ лечения хронических ран |
| CA2737452C (en) * | 2008-09-25 | 2018-05-22 | Vive Nano Inc. | Methods to produce polymer nanoparticles and formulations of active ingredients |
| US20100086576A1 (en) * | 2008-10-06 | 2010-04-08 | Myntti Matthew F | Antimicrobial composition and methods of making and using same |
| WO2012154953A2 (en) | 2011-05-10 | 2012-11-15 | Microbial Defense Systems, Llc | Antimicrobial solid and methods of making and using same |
| AU2012318331B2 (en) | 2011-10-08 | 2016-12-08 | Osartis Gmbh | Antimicrobial compositions and methods employing same |
| US10021876B2 (en) | 2013-05-02 | 2018-07-17 | Next Science IP Holdings Pty Ltd | High osmolarity antimicrobial composition containing one or more organic solvents |
-
2012
- 2012-05-10 WO PCT/US2012/037320 patent/WO2012154953A2/en not_active Ceased
- 2012-05-10 BR BR112013028673-3A patent/BR112013028673B1/pt not_active IP Right Cessation
- 2012-05-10 EP EP12781707.0A patent/EP2706845B1/en active Active
- 2012-05-10 US US13/468,767 patent/US10653133B2/en not_active Expired - Fee Related
- 2012-05-10 CA CA2835211A patent/CA2835211C/en active Active
- 2012-05-10 JP JP2014510466A patent/JP6463629B2/ja not_active Expired - Fee Related
- 2012-05-10 EP EP18203838.0A patent/EP3456200B1/en active Active
- 2012-05-10 AU AU2012253476A patent/AU2012253476B2/en not_active Ceased
-
2014
- 2014-09-14 US US14/485,748 patent/US10045527B2/en active Active
-
2018
- 2018-08-11 US US16/101,436 patent/US10609923B2/en active Active
-
2020
- 2020-04-10 US US16/846,218 patent/US11172677B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534259A (en) * | 1993-07-08 | 1996-07-09 | Liposome Technology, Inc. | Polymer compound and coated particle composition |
| US20030220039A1 (en) * | 1998-05-22 | 2003-11-27 | Fung-Jou Chen | Fibrous absorbent material and methods of making the same |
| WO2008016837A2 (en) * | 2006-07-31 | 2008-02-07 | Isp Investments Inc. | Aqueous compositions containing a hydrophobic material |
| WO2008024509A2 (en) * | 2006-08-24 | 2008-02-28 | Mallard Creek Polymers, Inc. | Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| WO2008076807A2 (en) * | 2006-12-13 | 2008-06-26 | Innovaform Technologies, Llc | Pesticidal aggregates |
Non-Patent Citations (1)
| Title |
|---|
| ANTONIRTTI, M et al. Macromolecules. 1994, Vol. 27, pages 6007-6011. * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2706845B1 (en) | 2021-06-23 |
| US10653133B2 (en) | 2020-05-19 |
| WO2012154953A2 (en) | 2012-11-15 |
| US10045527B2 (en) | 2018-08-14 |
| JP2014517834A (ja) | 2014-07-24 |
| JP6463629B2 (ja) | 2019-02-06 |
| CA2835211A1 (en) | 2012-11-15 |
| US20200260723A1 (en) | 2020-08-20 |
| BR112013028673A2 (pt) | 2016-08-09 |
| EP3456200B1 (en) | 2023-05-03 |
| US10609923B2 (en) | 2020-04-07 |
| EP2706845A2 (en) | 2014-03-19 |
| US11172677B2 (en) | 2021-11-16 |
| EP3456200A1 (en) | 2019-03-20 |
| AU2012253476A1 (en) | 2013-11-21 |
| BR112013028673B1 (pt) | 2020-06-16 |
| EP2706845A4 (en) | 2014-10-29 |
| US20120288469A1 (en) | 2012-11-15 |
| US20180343853A1 (en) | 2018-12-06 |
| US20150004203A1 (en) | 2015-01-01 |
| WO2012154953A3 (en) | 2013-01-17 |
| CA2835211C (en) | 2019-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11172677B2 (en) | Method for treating a fluid with an antimicrobial solid | |
| CA2911464C (en) | High osmolarity antimicrobial composition containing one or more organic solvents | |
| EP0391741B1 (en) | Polymeric broad-spectrum antimicrobial materials | |
| CN101574087A (zh) | 一种丙酸聚六亚甲基胍消毒剂及其制备方法 | |
| JP5735990B2 (ja) | 発芽誘導物質と抗菌剤とを含む組成物 | |
| EP2346324A2 (en) | Antimicrobial composition and methods of making and using same | |
| CN100407923C (zh) | 一种杀菌消毒剂及其应用 | |
| US7943158B2 (en) | Absorbent systems providing antimicrobial activity | |
| US5186946A (en) | Disinfectant with wide spectrum germicidal activity | |
| AU2017232218B2 (en) | Antimicrobial solid and methods of making and using same | |
| CN104434994A (zh) | 一种皮肤黏膜消毒液 | |
| Vasudevan et al. | Antimicrobial properties of iodine based products | |
| CA2062006C (en) | Disinfectant with wide spectrum germicidal activity | |
| JP2002301149A (ja) | 人工透析機器の消毒・洗浄剤組成物、および人工透析機器の消毒・洗浄方法 | |
| GB2292888A (en) | Wide spectrum water soluble biocide for medical instruments based on potassium monoperoxysulphate, malic & sulphamic acids, EDTA sodium salt & a glycol ether | |
| US20240099301A1 (en) | Disinfecting and Sanitizing Composition, Method for Preparing the Composition and Use of Same | |
| RU2543345C2 (ru) | Состав полимерной деконтаминирующей (дезинфицирующей) рецептуры на основе пероксосольвата фторида калия для получения прочных и малопроницаемых пленок, защищающих и деконтаминирующих поверхности в гермозамкнутых объемах различных объектов | |
| JP2004049786A (ja) | 人工透析機器の消毒・洗浄剤組成物、および人工透析機器の消毒・洗浄方法 | |
| CN115474609A (zh) | 消毒液及其制备方法和膜层 | |
| CN103814896A (zh) | 一种消毒液及其制造而成的湿纸巾 | |
| PL244085B1 (pl) | Środek dezynfekujący o przedłużonym działaniu | |
| CN106277241A (zh) | 消毒材料、物理自带消毒防腐杀菌除藻毒素净化水质盛水器 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: NEXT SCIENCE IP HOLDINGS PTY LTD Free format text: FORMER OWNER(S): NEXT SCIENCE, LLC |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |